You are here

Pharma CEOs

Under-pressure Allergan backs a CEO-chairman job split—just not right now

Under-pressure Allergan backs a CEO-chairman job split—just not right now

Fierce Pharma

Flag link:

AZ’s CEO dismisses “fake news” about his imminent departure

AZ’s CEO dismisses “fake news” about his imminent departure

Pharmaforum

Flag link:

Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns

Pharma Novartis chief’s 2018 take-home pay suffers—not from Cohen but from low-grade returns

Fierce Pharma

Flag link:

Leadership In An Age Of Disruption: Q&A With Abbott Chairman And CEO Miles White

Leadership In An Age Of Disruption: Q&A With Abbott Chairman And CEO Miles White

Forbes

Flag link:

Novartis CEO lauds Trump administration plan to overhaul rebates

Novartis CEO lauds Trump administration plan to overhaul rebates

Yahoo/Reuters

Flag link:

Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day

Gilead executives predict patience—and some deal scouting—from new CEO Daniel O'Day

Fierce Pharma

Gilead Sciences

Flag link:

As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices

As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices

BioSpace

Flag link:

CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity

CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity

Stat

Flag link:

Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech

Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech

Endpoints

Alexander Hardy

Flag link:

Has Abbott's Acquisitive Miles White Made His Last Big Deal?

Has Abbott's Acquisitive Miles White Made His Last Big Deal?

Forbes

Flag link:

Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard

Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard

Forbes

Flag link:

Want to buy Clovis? Step up. ‘Everybody knows where to find me,’ CEO says

Want to buy Clovis? Step up. ‘Everybody knows where to find me,’ CEO says

Fierce Pharma

Patrick Mahaffy

Clovis Oncology

Flag link:

Kare Schultz, Teva CEO, announces new data showing the worst phase is now over

Kare Schultz, Teva CEO, announces new data showing the worst phase is now over

GoinPharma

Teva Pharmaceutical

Flag link:

JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says

JPM: Why hasn't Merck been making deals? It's not for lack of trying, CEO says

Fierce Pharma

Flag link:

3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear

3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear

Motley Fool

Flag link:

Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises

Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises

Fierce Pharma

Flag link:

John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?

John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?

Endpoints

Melinta Therapeutics

Flag link:

New Pfizer CEO's top priorities? Think China and pipeline, not deals: analyst

New Pfizer CEO's top priorities? Think China and pipeline, not deals: analyst

Fierce Pharma

Flag link:

AbbVie streamlines management team to 4 executives under CEO Gonzalez

AbbVie streamlines management team to 4 executives under CEO Gonzalez

Fierce Pharma

Richard Gonzalez

Flag link:

Alnylam CEO talks politics, gene therapy and not becoming Pfizer

Alnylam CEO talks politics, gene therapy and not becoming Pfizer

BioPharma Dive

John Maraganore

Flag link:

Pages